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CR, SK) and insurance records (HU). Direct costs from the payer’s perspective were
based on published national sources (CR, SK), DRG lists (PL) and the insurance
records (HU). RESULTS: The incidence of hospitalized bacteraemia/sepsis and
meningitis per 100,000 person years were: 2.07 and 1.34 (CR), 1.2 and 0.49 (SK), 0.66
and 0.32 (PL), and 3.16 and 1.01 (HU). The case fatality rate was: 31% and 25%, 12%
and 25%, 40% and 63%, and 11% and 29%. An exponential increase in both measures
was apparent with advancing age. The total economic burden of IPD in adults over
50 was: EUR 666,050; 159,528; 180,015 and 140,249. Adults 65, who represent 41%
of the combined population, account for 54% of the costs. CONCLUSIONS: The IPD
burden in adults increases with age, and is associated with a high risk of death.
Higher incidence in HU obtained from insurance records seems to more reliably
reflect the reality and highlights systematic underreporting of national surveil-
lance systems.
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OBJECTIVES: To estimate the stroke related disease burden in terms of health care
resource utilization and average per-patient costs among patients with a prior
diagnosis of non-valvular atrial fibrillation (NVAF) in India. METHODS: Data were
collected retrospectively in three large multidisciplinary community hospitals in
three cities in India. Medical charts of 400 patients diagnosed with stroke and NVAF
from June 1, 2011 to September 1, 2011 were reviewed. Data abstracted were demo-
graphic characteristics, clinical diagnosis, risk factors, comorbid conditions, date of
diagnosis/admission, date of discharge, and types of inpatient procedures. Data
regarding outpatient services such as physician visits, laboratory tests, INR moni-
toring, diagnostic tests, nursing services, and speech/physiotherapy over a three
month period post-discharge were obtained via patient follow-up surveys. Costs
associated with inpatient services were obtained from hospital discharge bills and
the pricing menu of the three hospitals. RESULTS: The mean age of patients in the
study was 59 (SD 10) and the majority of patients (62%) were male. Of the 400
patients, 61% had ischemic stroke and about 60% of the patients were moderate to
moderate-severe disabled based on the modified Rankin Scale. The mean length of
stay for patients with ischemic stroke was 16 days (SD 4). The direct medical costs
for patients with moderate or more severe ischemic stroke (inpatient and outpa-
tient) over the 3 month follow-up period was Indian rupees, Rs 130,976 (SD 3,913)
with inpatient hospital costs accounting for a major portion (Rs 114,202) of the
overall costs (per patient). CONCLUSIONS: The findings of the study indicated that
the acute treatment for 3 months post ischemic stroke among NVAF patients im-
poses considerable economic burden (US $7,138) among patients in India. As inpa-
tient costs are major cost drivers, clinical efforts should focus on timely manage-
ment of NVAF induced strokes and use of preventive treatments.
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OBJECTIVES:To calculate the health care cost of traffic accidents occurring in night
or daylight under low visibility. METHODS: Data on traffic accidents derive from
the database of Hungarian Central Statistical Office (HCSO). We assessed the cost of
both health services in kind and health services in cash. The direct cost related to
traffic accidents were derived from the financial database of the National Health
Insurance Fund Administration, the only health care financing agency in Hungary
(Hungarian DRG point system version 5.0). Cost of benefits in cash was calculated
with an average sick pay. The average recovery period of patients with traffic
accidents was assumed 4 months. RESULTS: A total of 20635 persons were injured
and 1106 persons were died on the road by traffic accident. 45 percent of casualty
has been taken in night or daylight under low visibility. Average cost of restricted
visibility accidents is 510886 HUF per capita (approx. 2041 EURO). We calculated an
average sick pay 119365 HUF (approx. 477 Euro) per capita per month. The expen-
ditures of the National Health Insurance Fund Administration could easily reach
the 17 billion HUF (approx. 67.9 million Euro) per years. CONCLUSIONS: Traffic
accidents and subsequent medical conditions are important burden for the Hun-
garian health insurance system with an annual expenditure of 17 billion HUF (97,9
million EURO). Better illumination, law regulation, appropriate education and traf-
fic instructions might decrease the costs related to accidents on the road.
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OBJECTIVES: Gastrointestinal bleeding is one of the most common causes of med-
ical attention in-hospital demand, with high impact on morbidity, mortality and
costs of care. The aim of this study was to evaluate from the public payer perspec-
tive in Mexico, the cost of care of patients with gastrointestinal bleeding.
METHODS: Through review of medical records of patients with gastrointestinal
bleeding from January to March 2012 in a hospital in the Mexican Social Security
Institute (IMSS) we evaluated the length of hospital stay, laboratory tests, endos-
copy and pharmacological treatment prescribed. We used as reference the 2011
database of the institution and expressed the cost in U.S. dollars (USD) at an ex-
change rate of 13.72 Mexican pesos/USD [June 2012] and calculated the average cost
per patient, we identified the component of major cost and identify the factor
associated with higher cost. RESULTS:We included 70 patients with mean age 68
14 years, 61% were women. 80% of cases had a comorbidity, the most frequent was
systemic arterial hypertension (90%). On average hospital stay was 8 4 days. The
average cost per patient was 3.776 USD (1.490 USD- 8.180). The major cost compo-
nent was hospital stay accounting for 81% of total costs. In patients Age over 85
years, the presence of comorbidities or gender were no associated with higher cost
(p 0.05). CONCLUSIONS: Gastrointestinal bleeding is a major cause of resource
utilization for the IMSS, the main component are the days of hospital stay which
cause a high economic impact on accessibility to other hospital claims.
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OBJECTIVES: In France, 4-10% of the population is annually affected by influenza.
This represents direct and indirect costs, which vary according to the dominant
influenza virus strain circulating. Policy makers are interested in its burden, for
better allocating resources for prevention and control measures. As international
literature regarding seasonal influenza B is rare and not entirely applicable in
France, our study aims to assess its costs in 2010/2011 under the French Health
Insurance perspective. METHODS: Cases: patients of all ages, consulting for an
acute respiratory infection a physician, member of an influenza surveillance net-
work in France (GROG network), completing the routine clinical form and whose
nasopharyngeal swab was lab confirmed positive for influenza B. Physicians com-
pleted follow-up questionnaires 7 and 28 days after swabbing. Costs (consults,
drugs, exams, hospitalization and daily allowances) were assessed for each pa-
tient. Treatments costs were modelled using linear, tobit and probit regressions
(variables: costs, risk factor, vaccination, age group). Total costs estimation for the
French Health Insurance were calculated by multiplying total costs per patient, flu
attack rate and population. RESULTS: N201 patients were included. Influenza B
mean cost was 90.63€ (SD 132.76) per patient. Risk factors or influenza vaccine
status did not impact the mean cost. In children and older people these costs were
very similar (0-4 yo76.74€, 5-14 yo75.45€, 65 yo72.50€). Main cost items were
follow-up consults and antibiotics. For adults, costs almost doubled, reaching ap-
proximately 141.25€ per patient, due to work absenteeism. Total influenza B costs
for the National Health Insurance were estimated on almost 400 million Euros in
France during 2010/11. CONCLUSIONS: The results show that in a season where
influenza B is dominant, it causes an important economic impact. Further investi-
gations of strategies (vaccines) for reducing influenza B cases, providing evidence
for policy-makers’ decisions are in progress.
PHS27
EVALUATION OF THE CLINICAL AND ECONOMIC BURDEN OF THE HUMAN
IMMUNODEFICIENCY VIRUS IN UNITED STATES VETERAN PATIENTS
Wang L1, Baser O2, Huang A1, Li L1, Fritschel EK1, Xie L3
1STATinMED Research, Dallas, TX, USA, 2STATinMED Research/The University of Michigan,
Ann Arbor, MI, USA, 3STATinMED Research, Ann Arbor, MI, USA
OBJECTIVES: To assess the clinical and demographic characteristics, utilization,
and cost patterns of human immunodeficiency virus (HIV) patients in the U.S.
veteran population. METHODS: A retrospective analysis was performed using the
Veterans Health Administration (VHA) Medical SAS Datasets from October 1, 2007
to September 30, 2011. All U.S. veteran beneficiaries diagnosed with HIV were iden-
tified using International Classification of Disease 9th Revision Clinical Modifica-
tion (ICD-9-CM) diagnosis codes 042.xx and V08.xx. Descriptive statistics were cal-
culated as means  standard deviation (SD) and percentages to measure
demographic, cost, and utilization distribution in the sample. RESULTS: A total of
2,432 patients were diagnosed with HIV, who were most frequently designated as
Caucasian (n1,201, 49.38%) and often lived in the southern parts of the United
States (n905, 37.21%). Common comorbidities included hypertension (n1,531,
55.55%) and diabetes (n558, 22.94%). Survival rates were high for all age groups
(age 39: 98.21%; 40-64 years: 93.48%; 65: 87.11%). Outpatient services were uti-
lized by 99.92% of HIV patients, followed by inpatient (20.44%) and outpatient emer-
gency room (ER) visits (7.11%). An average number of 0.39 inpatient visits and 21.01
outpatient visits per patient occurred during the 1-year follow-up period. Outpa-
tient office ($10,558, SD$12,856), outpatient ER ($36, SD$240), and inpatient
($8,371, SD$35,444) values contributed to follow-up health care expenditures.
CONCLUSIONS: U.S. veterans with HIV experienced a high average number of
outpatient visits during the follow-up period as well as frequent comorbidities and
high survival rates. These may have translated to the high outpatient expenses
evident in the study.
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OBJECTIVES:The management of atrial fibrillation (AF) represents a significant and
increasing burden on the UK National Health Service (NHS). Understanding this
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